Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis

Repurposing Diflunisal for Familial Amyloid Polyneuropathy

(2015) John L. Berk et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy

(2014) Etta J. Vinik et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis

(2013) Thibaud Damy et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis

(2013) Giampaolo Merlini et al.   Journal of Cardiovascular Translational Research

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

(2013) Jennifer H. Pinney et al.   Journal of the American Heart Association

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective

(2012) C. Rapezzi et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

(2012) T. Coelho et al.   NEUROLOGY

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

(2012) C. E. Bulawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)

(2011) H. E. Wilczek et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Familial amyloid polyneuropathy

(2011) Violaine Planté-Bordeneuve et al.   LANCET NEUROLOGY

Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study

(2010) Anju Bhardwaj et al.   AMERICAN HEART JOURNAL

Transthyretin-related amyloidoses and the heart: a clinical overview

(2010) Claudio Rapezzi et al.   Nature Reviews Cardiology

Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis

(2009) Lawreen H. Connors et al.   AMERICAN HEART JOURNAL

Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival

(2009) Sadahisa Okamoto et al.   LIVER TRANSPLANTATION

Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses

(2008) Yoshiki Sekijima et al.   CURRENT PHARMACEUTICAL DESIGN

Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?

(2008) O. B. Suhr et al.   JOURNAL OF INTERNAL MEDICINE